(Q48137486)

9 February 2018

title

Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist (English)

1 reference

9 February 2018

0 references

Iida M

1

1 reference

9 February 2018

Miyazaki I

2

1 reference

9 February 2018

Tanaka K

3

1 reference

9 February 2018

Kabuto H

4

1 reference

9 February 2018

Iwata-Ichikawa E

5

1 reference

9 February 2018

Ogawa N

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

9 February 2018

published in

Brain Research

1 reference

9 February 2018

volume

838

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

51-59

1 reference

9 February 2018

Oxygen free radicals and Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Brain Peroxidase and Catalase in Parkinson Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Microsomal lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Psychotic complications of long-term levodopa treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Pergolide scavenges both hydroxyl and nitric oxide free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

The rationale for the use of dopamine agonists in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Oxidative stress and the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

New insights into the cause of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Glutathione peroxidase activity in Parkinson's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Scavenging effects of dopamine agonists on nitric oxide radicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Assay of superoxide dismutase activity in tumor tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Long-lasting effect of ceruletide on dyskinesia and monoaminergic neuronal pathways in rats treated with iminodipropionitrile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

A radical hypothesis for neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by a partial ergoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Mortality associated with early and late levodopa therapy initiation in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Dopamine turnover and glutathione oxidation: implications for Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Inhibitory effects of bromocriptine on phospholipid peroxidation induced by dopa and iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Antioxidant properties of bromocriptine, a dopamine agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

inferred from DOI database lookup

7 January 2021

based on heuristic

L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901688-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(99)01688-1

1 reference

9 February 2018

release_bube7tvnirgslgxz3xxkuwhoji

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bube7tvnirgslgxz3xxkuwhoji

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 February 2018